ATM and pancreatic neoplasm: In the present study, we provide pre-clinical evidence that ATM disrupts aPKC signaling and inhibits the transformed phenotype in pancreatic cancer, and demonstrate that aPKCs are the major target of ATM-mediated inhibition of the transformed phenotype.